Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031

globenewswire.com
BSX Boston Scientific is listed as a key player in the peripheral vascular devices market, which is projected for significant growth. The article does not provide specific sentiment towards Boston Scientific itself, but its inclusion as a major player in a growing market suggests potential. MDT Medtronic Plc is identified as a major industry player in the peripheral vascular devices market, a sector expected to experience substantial growth. The article does not offer specific sentiment for Medtronic, but its position in a growing market is noteworthy. ABT Abbott is mentioned as a key player in the peripheral vascular devices market, which is forecasted to grow significantly. The article does not express a specific sentiment towards Abbott, but its inclusion as a major company in this expanding market is relevant. BDX Becton, Dickinson and Company is listed as a major industry player in the peripheral vascular devices market, which is projected for considerable growth. The article does not provide specific sentiment for BDX, but its role in a growing sector is highlighted. MMSI Merit Medical Systems is listed as a key player in the peripheral vascular devices market, which is projected for significant growth. The article does not provide specific sentiment towards Merit Medical Systems, but its inclusion as a major player in a growing market suggests potential. PEN Penumbra, Inc. is mentioned as a key player in the peripheral vascular devices market, a sector anticipated to grow significantly. The article does not offer specific sentiment for Penumbra, but its presence in a growing market is noted. PHG Koninklijke Philips is named as a major industry player in the peripheral vascular devices market, which is expected to experience substantial growth. The article does not provide specific sentiment for Philips, but its inclusion in a growing market is relevant.

Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031 Dublin, June 02, 2026 (GLOBE NEWSWIRE) -- The "Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The peripheral vascular devices market is projected to reach USD 13.22 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 5.7%. This market is experiencing significant growth, largely driven by the rising prevalence of peripheral artery disease (PAD) and other vascular disorders. These conditions are linked to an aging population, alongside increasing rates of diabetes, obesity, and smoking. Innovations in endovascular devices, such as drug-coated balloons, next-generation stents, atherectomy systems, and embolic protection devices, are enhancing clinical outcomes and expanding patient treatment options. The preference for outpatient and ambulatory surgical center-based procedures, bolstered by favorable reimbursement policies in many regions, is further facilitating the adoption of these devices.

Furthermore, market growth is attributed to heightened awareness about early diagnosis and treatment, enhanced healthcare infrastructure in developing countries, and significant investments by leading manufacturers in innovation and clinical research.

The old/normal balloons segment is expected to grow at the highest CAGR in the angioplasty balloons market during the forecast period. The angioplasty balloons market is witnessing increased demand for plain (standard) balloons due to their cost-effectiveness, availability of expertise, and versatility across interventions. These balloons are favored for lesion preparation and pre- and post-dilatation procedures, particularly where drug-coated options are unnecessary or uninsured. Despite the rise of advanced balloon technologies, standard balloons continue to thrive in less demanding, high-volume markets, primarily in developing regions, due to their user-friendliness, reliability, and compatibility with various stent systems.

The embolic protection devices segment is expected to grow at the highest CAGR in the hemodynamic flow alteration devices market. The demand for embolic protection devices is rising due to their use in complex endovascular and structural heart procedures, where the risk of distal embolization is high. Growing awareness of complications such as stroke and organ ischemia, especially during carotid, peripheral, and transcatheter interventions, has accelerated their clinical adoption. Device improvements enhancing capture efficiency and vessel compatibility have bolstered the market. This trend is supported by emerging guidelines and the expansion of minimally invasive procedures.

Based on end users, the ambulatory surgical centers segment is projected to grow at the highest CAGR in the peripheral vascular devices market. The growth is primarily driven by ambulatory surgery centers (ASCs) facilitating minimally invasive procedures emphasizing outpatient care. ASCs offer benefits like reduced costs, rapid patient turnover, and operational efficiency, appealing to payers and patients. Innovations in vascular devices, such as miniaturized imaging systems and low-profile catheters, enable complex procedures in ASC settings. Factors such as favorable reimbursement, physician ownership models, and growing patient preference for same-day discharge bolster ASC adoption in this market.

The Asia Pacific is estimated to register the highest CAGR during the forecast period. The primary growth driver in the APAC region is the increasing incidences of PAD and diabetes, supported by a large aging population and lifestyle shifts. China, India, and Japan lead in adopting vascular devices, driven by developing healthcare infrastructure and rising expenditures. Awareness of minimally invasive interventions, more skilled specialists, and expanding reimbursement coverage further fuel market growth. Additionally, low-cost manufacturing and strategic expansions by global device firms propel growth in APAC.

Key Players Major industry players include Boston Scientific, Medtronic Plc, Abbott, Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, Merit Medical Systems, Penumbra, Inc., Koninklijke Philips, Stryker, Cordis, W.L. Gore & Associates, Biotronik Stryker, Endologix LLC, and Cook Medical.

Research Coverage The report analyzes the peripheral vascular devices market, estimating market size and growth potential across segments like angioplasty stents, endovascular aneurysm repair stent grafts, and more. It includes a product portfolio matrix and competitive analysis, detailing company profiles, offerings, and strategies.

Reasons to Buy the Report The report provides revenue estimates for the peripheral vascular devices market and subsegments, helping stakeholders understand the competitive landscape and develop effective strategies. It highlights market dynamics, key drivers, constraints, challenges, and opportunities.

This report provides insights into the following pointers:

Key Attributes:

Key Topics Covered:

4 Market Dynamics

13 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/dmmato

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.